Oxford Bioscience Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 222

  • Portfolio
  • 5

  • Exits
  • 130

Exits

Oxford Bioscience Partners General Information

Description

Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts. The firm invested in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. Oxford invested in pre-commercial stage businesses that solve problems throughout the international life science market.

Contact Information

Website
www.oxbio.com
Year Founded
1992
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • P.O. Box 207
  • 12 Giles Place
  • Mansfield, MA 02048
  • United States

Oxford Bioscience Partners Investments (222)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Yolia Health 01-Jan-2017 Later Stage VC 000 Therapeutic Devices Generating Revenue 00000000 0000000
0000000000 0000000 15-Jun-2015 00000 00000 0000 Biotechnology Generating Revenue 00000000 0000000
0000000 19-Nov-2014 00000 00000 Energy Storage Out of Business 0000000 00000
00000 (0000 000000 28-Apr-2014 00000 00000 Food Products Generating Revenue
00000000 000000000 30-Aug-2013 00000 00000 000.00 Pharmaceuticals Out of Business 0000 000000
00 0000000000 01-Aug-2013 00000 00000 00.000 Biotechnology Generating Revenue
0000000 0000000000 01-Aug-2013 00000 00000 0000 Pharmaceuticals Generating Revenue/Not Profitable 0000000 000000000 000
0000 000000000000 17-Jan-2013 00000 00000 000 Energy Production Out of Business 0000000 00000
PharmAbcine 11-Jun-2012 Early Stage VC 00.00 Drug Discovery Generating Revenue 0. 00000000000 000 00.0
Mitralign 16-May-2012 Later Stage VC 0000 Surgical Devices Profitable 0000000 000000
You’re viewing 10 of 222 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Bioscience Partners Exits (130)

Company Name Exit Date Exit Type Exit Size
GreenLight Biosciences 04-Feb-2022 Reverse Merger 00000
0000000 0000000000 07-Sep-2021 000000000000000000
0000000 0000000000 27-Dec-2019 0000000000: 000000
00 0000000000 26-Dec-2019 000 000.00
000000000 12-Mar-2019 000000000000000000
00000000000 21-Nov-2018 000
00000000 000000000 22-Nov-2017 000 00 00000000
0000000 0000000000 03-Nov-2017 0000000 000000
Selventa 30-Jun-2017 Out of Business
Glori Energy 24-Mar-2017 Merger/Acquisition
You’re viewing 10 of 130 exits. Get the full list »

Oxford Bioscience Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Oxford Bioscience Partners‘s full profile, request access.

Request a free trial

Oxford Bioscience Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Oxford Bioscience Partners Team (27)

Name Title Deals Funds Boards Office
Daniel Cole Venture Partner 00 0 0 Boston, MA
You’re viewing 1 of 27 team members. Get the full list »